Article Information
History
- March 4, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Faisal Salman Alshaikha,b,*,
- Oula Nawaf Sindia,
- Brian Godmana,c,d,†,
- R Andrew Seatond,e and
- Amanj Kurdig,h,a,d
- aStrathclyde Institute of Pharmacy and Biomedical Science (SIPBS), University of Strathclyde, Glasgow, UK
- bPharmaceutical Services, Bahrain Defence Force Military Hospital, Kingdom of Bahrain
- cCentre of Medical and Bio-allied Health Sciences Research, Ajman University, United Arab Emirates
- dDivision of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa
- eQueen Elizabeth University Hospital, Glasgow, UK
- fScottish Antimicrobial Prescribing Group, Healthcare Improvement Scotland, Glasgow, UK
- gCenter of Research and strategic studies, Lebanese French University, Erbil, Kurdistan Region Government, Iraq
- hDepartment of Pharmacology and Toxicology, College of Pharmacy, Hawler Medical University, Erbil, Kurdistan Region Government, Iraq
- ↵*Corresponding Author:
Faisal Alshaikh, Strathclyde Institute of Pharmacy and Biomedical Science, University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, Scotland, UK, Email:
ph.faisalalshaikh{at}gmail.com, Telephone:
(00973)36805888 - ↵†Co-corresponding Author:
Brian Godman, Email:
briangodman{at}outlook.com